Jozef Madzo to Histone Deacetylase Inhibitors
This is a "connection" page, showing publications Jozef Madzo has written about Histone Deacetylase Inhibitors.
Connection Strength
0.230
-
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia. Invest New Drugs. 2015 Apr; 33(2):371-9.
Score: 0.123
-
The identification of (ETV6)/RUNX1-regulated genes in lymphopoiesis using histone deacetylase inhibitors in ETV6/RUNX1-positive lymphoid leukemic cells. Clin Cancer Res. 2007 Mar 15; 13(6):1726-35.
Score: 0.072
-
Transcriptional Selectivity of Epigenetic Therapy in Cancer. Cancer Res. 2017 01 15; 77(2):470-481.
Score: 0.035